https://european-biotechnology.net/wp-content/uploads/2025/01/inflarx_antiko__rper-web.webp540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-01-16 14:36:222025-01-16 14:36:22InflaRx secures European Commission approval for ARDS drug
https://european-biotechnology.net/wp-content/uploads/2025/01/gr3_lrg-1030x730-1.jpg7301030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-01-13 08:42:232025-01-13 08:42:23First in vivo CAR gene therapy trial in Europe approved
https://european-biotechnology.net/wp-content/uploads/2025/01/synapse-Image-by-Pete-Linforth-from-Pixabay.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-01-10 09:56:352025-01-10 09:56:35Angelini Ventures co-leads €20m Series A to advance RNA therapeutics for neurological disorders
https://european-biotechnology.net/wp-content/uploads/2025/01/VC_money-1030x686-1.jpg6861030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-01-09 09:15:042025-01-09 09:15:04USD410m Mega Series A for yet another GLP-1 play?
https://european-biotechnology.net/wp-content/uploads/2025/01/home-img-e1736329767777-1030x488-1.jpg4881030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-01-09 09:05:412025-01-09 13:02:02Jeito Capital leads $67.5m Series B financing for cardiovascular gene therapy
